Jazz Pharmaceuticals to Participate in the 24th Annual Needham Virtual Healthcare Conference
Jazz Pharmaceuticals (Nasdaq: JAZZ) has announced its participation in the 24th Annual Needham Healthcare Conference. The company's management will engage in a fireside chat scheduled for Wednesday, April 9, 2025, at 9:45 a.m. PT / 12:45 p.m. ET / 5:45 p.m. IST.
An audio webcast of the discussion will be accessible through the Investors section of Jazz Pharmaceuticals' website, with replays available for 30 days. The company, headquartered in Dublin, Ireland, is a global biopharma organization focused on developing life-changing medicines for patients with serious diseases, particularly in areas with therapeutic options.
Jazz maintains a diverse portfolio including:
- Leading therapies for sleep disorders and epilepsy
- Growing portfolio of cancer treatments
- Innovative therapeutics pipeline in oncology and neuroscience
Jazz Pharmaceuticals (Nasdaq: JAZZ) ha annunciato la sua partecipazione alla 24ª Conferenza Sanitaria Annuale Needham. La direzione dell'azienda parteciperà a una chiacchierata informale programmata per mercoledì 9 aprile 2025, alle 9:45 PT / 12:45 ET / 17:45 IST.
Un webcast audio della discussione sarà accessibile attraverso la sezione Investitori del sito web di Jazz Pharmaceuticals, con repliche disponibili per 30 giorni. L'azienda, con sede a Dublino, Irlanda, è un'organizzazione biopharma globale focalizzata sullo sviluppo di farmaci che cambiano la vita per pazienti con malattie gravi, in particolare in aree con opzioni terapeutiche limitate.
Jazz mantiene un portafoglio diversificato che include:
- Terapie leader per i disturbi del sonno e l'epilessia
- Portafoglio in crescita di trattamenti per il cancro
- Pipeline terapeutiche innovative in oncologia e neuroscienze
Jazz Pharmaceuticals (Nasdaq: JAZZ) ha anunciado su participación en la 24ª Conferencia Anual de Salud de Needham. La dirección de la empresa participará en una charla informal programada para el miércoles 9 de abril de 2025, a las 9:45 a.m. PT / 12:45 p.m. ET / 5:45 p.m. IST.
Un webcast de audio de la discusión estará disponible a través de la sección de Inversores del sitio web de Jazz Pharmaceuticals, con repeticiones disponibles durante 30 días. La empresa, con sede en Dublín, Irlanda, es una organización biopharma global centrada en desarrollar medicamentos que cambian la vida para pacientes con enfermedades graves, particularmente en áreas con opciones terapéuticas limitadas.
Jazz mantiene un portafolio diverso que incluye:
- Terapías líderes para trastornos del sueño y epilepsia
- Portafolio en crecimiento de tratamientos oncológicos
- Pipeline terapéutico innovador en oncología y neurociencia
재즈 제약 (Nasdaq: JAZZ)는 제24회 니드햄 헬스케어 컨퍼런스에 참여한다고 발표했습니다. 회사 경영진은 2025년 4월 9일 수요일 오전 9:45 PT / 오후 12:45 ET / 오후 5:45 IST에 예정된 화상 대화에 참여할 것입니다.
토론의 오디오 웹캐스트는 재즈 제약 웹사이트의 투자자 섹션을 통해 접근할 수 있으며, 30일 동안 다시 볼 수 있습니다. 아일랜드 더블린에 본사를 둔 이 회사는 중병 환자를 위한 삶을 변화시키는 약물을 개발하는 데 중점을 둔 글로벌 바이오 제약 조직입니다.
재즈는 다음과 같은 다양한 포트폴리오를 유지하고 있습니다:
- 수면 장애 및 간질에 대한 선도적인 치료법
- 성장하는 암 치료 포트폴리오
- 온콜로지 및 신경 과학 분야의 혁신적인 치료제 파이프라인
Jazz Pharmaceuticals (Nasdaq: JAZZ) a annoncé sa participation à la 24e Conférence Annuelle de Santé Needham. La direction de l'entreprise participera à une discussion informelle prévue pour le mercredi 9 avril 2025, à 9h45 PT / 12h45 ET / 17h45 IST.
Un webinaire audio de la discussion sera accessible via la section Investisseurs du site Web de Jazz Pharmaceuticals, avec des rediffusions disponibles pendant 30 jours. L'entreprise, dont le siège est à Dublin, en Irlande, est une organisation biopharmaceutique mondiale axée sur le développement de médicaments qui changent la vie pour les patients atteints de maladies graves, en particulier dans des domaines avec des options thérapeutiques limitées.
Jazz maintient un portefeuille diversifié comprenant :
- Thérapies de pointe pour les troubles du sommeil et l'épilepsie
- Portefeuille croissant de traitements contre le cancer
- Pipeline thérapeutique innovant en oncologie et en neurosciences
Jazz Pharmaceuticals (Nasdaq: JAZZ) hat seine Teilnahme an der 24. jährlichen Needham Healthcare Conference bekannt gegeben. Das Management des Unternehmens wird an einem informellen Gespräch teilnehmen, das für Mittwoch, den 9. April 2025, um 9:45 Uhr PT / 12:45 Uhr ET / 17:45 Uhr IST geplant ist.
Ein Audio-Webcast der Diskussion wird über den Bereich Investoren auf der Website von Jazz Pharmaceuticals zugänglich sein, mit Wiederholungen, die 30 Tage lang verfügbar sind. Das Unternehmen mit Sitz in Dublin, Irland, ist eine globale Biopharma-Organisation, die sich auf die Entwicklung lebensverändernder Medikamente für Patienten mit schweren Krankheiten konzentriert, insbesondere in Bereichen mit begrenzten Therapieoptionen.
Jazz hält ein vielfältiges Portfolio, das Folgendes umfasst:
- Führende Therapien für Schlafstörungen und Epilepsie
- Wachsendes Portfolio von Krebsbehandlungen
- Innovative therapeutische Pipeline in Onkologie und Neurowissenschaften
- None.
- None.
An audio webcast of the fireside chat will be available via the Investors section of the Jazz Pharmaceuticals website at https://investor.jazzpharma.com/investors/events-presentations. A replay of the webcasts will be archived on the website for 30 days.
About Jazz Pharmaceuticals
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) is a global biopharma company whose purpose is to innovate to transform the lives of patients and their families. We are dedicated to developing life-changing medicines for people with serious diseases — often with limited or no therapeutic options. We have a diverse portfolio of marketed medicines, including leading therapies for sleep disorders and epilepsy, and a growing portfolio of cancer treatments. Our patient-focused and science-driven approach powers pioneering research and development advancements across our robust pipeline of innovative therapeutics in oncology and neuroscience. Jazz is headquartered in
Contacts:
Investors:
Jeff Macdonald
Executive Director, Investor Relations
Jazz Pharmaceuticals plc
InvestorInfo@jazzpharma.com
Media:
Kristin Bhavnani
Head of Global Corporate Communications
Jazz Pharmaceuticals plc
CorporateAffairsMediaInfo@jazzpharma.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/jazz-pharmaceuticals-to-participate-in-the-24th-annual-needham-virtual-healthcare-conference-302412294.html
SOURCE Jazz Pharmaceuticals plc
FAQ
When is Jazz Pharmaceuticals (JAZZ) presenting at the Needham Healthcare Conference 2025?
How long will Jazz Pharmaceuticals' (JAZZ) Needham Conference webcast be available for replay?
What are the main therapeutic areas in Jazz Pharmaceuticals' (JAZZ) current portfolio?
Where can investors access Jazz Pharmaceuticals' (JAZZ) Needham Conference presentation?
What are the key focus areas of Jazz Pharmaceuticals' (JAZZ) R&D pipeline?
